Page last updated: 2024-09-03

gefitinib and Alopecia

gefitinib has been researched along with Alopecia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, PC; Chu, CY; Shih, YH1
Donovan, JC; Ghazarian, DM; Shaw, JC1
Fujii, N; Fujimoto, N; Kato, T; Nagao, T; Nakanishi, G; Tanaka, T; Toda, N1
Burt, PA; Lee, LW1
Graves, JE; Heffernan, MP; Jones, BF; Lind, AC1

Reviews

1 review(s) available for gefitinib and Alopecia

ArticleYear
Erosive pustular dermatosis of the scalp-like eruption due to gefitinib: case report and review of the literature of alopecia associated with EGFR inhibitors.
    Dermatology (Basel, Switzerland), 2012, Volume: 225, Issue:1

    Topics: Aged; Alopecia; Antineoplastic Agents; Asian People; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Quinazolines; Scalp Dermatoses

2012

Other Studies

4 other study(ies) available for gefitinib and Alopecia

ArticleYear
Severe refractory scarring alopecia associated with combinational use of ficlatuzumab (AV-299) and gefitinib.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jul-10, Volume: 31, Issue:20

    Topics: Aged; Alopecia; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cicatrix; Female; Follow-Up Studies; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Quinazolines; Risk Assessment; Severity of Illness Index

2013
Scarring alopecia associated with use of the epidermal growth factor receptor inhibitor gefitinib.
    Archives of dermatology, 2008, Volume: 144, Issue:11

    Topics: Aged; Alopecia; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Cicatrix; Disease Progression; ErbB Receptors; Fatal Outcome; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Male; Quinazolines; Risk Assessment

2008
Hair growth after gefitinib treatment.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2005, Volume: 17, Issue:6

    Topics: Alopecia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; ErbB Receptors; Gefitinib; Hair; Humans; Hypertrichosis; Lung Neoplasms; Male; Middle Aged; Quinazolines

2005
Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:2

    Topics: Aged; Alopecia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Gefitinib; Humans; Inflammation; Lung Neoplasms; Quinazolines; Time Factors

2006